12/18/20 16:29 | 12/17/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Karsen Perry A | MA | D | | M.d | 1,638 | 18.45 | 0 | 89 | | 5 | D | | | | | | | | | | | | | | |
12/18/20 16:29 | 12/17/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Karsen Perry A | MA | D | | S.d | -4,754 | 53.55 | 0 | -89 | -95 | 5 | D | | | | | | | | | | | | | | |
6/7/17 18:18 | 6/5/17 | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | CA | D | | P | 35 | 3.46 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
2/2/17 17:03 | 2/1/17 | JNCE | Jounce Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Karsen Perry A | MA | D | | P | 80 | 16.00 | 23 | 5 | New | 5 | D | | | | | | | | -1 | 0 | 11 | 38 | 59 | | |
12/18/15 16:21 | 12/17/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 0 | 0.00 | 33 | 8 | 12 | 68 | D | 40 | -1 | -4 | -9 | -7 | 0 | 0 | 2 | 1 | 11 | -2 | -8 | -10 | 6 |
5/15/15 16:29 | 5/13/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 1,491 | 48.94 | 33 | 30 | 85 | 66 | D | 77 | 52 | 7 | -1 | 1 | -3 | 7 | 1 | 1 | 1 | -4 | 13 | -3 | -13 |
5/15/15 16:29 | 5/13/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -5,425 | 115.00 | 33 | -47 | -42 | 66 | D | 77 | 52 | 7 | -1 | 1 | -3 | 7 | 1 | 1 | 1 | -4 | 13 | -3 | -13 |
5/4/15 19:15 | 4/30/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 0 | 0.00 | 33 | 11 | 16 | 83 | D | 90 | 49 | 5 | -7 | -14 | -5 | -4 | -3 | -2 | 3 | 4 | 19 | 14 | -4 |
3/3/15 16:24 | 3/1/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 0 | 0.00 | 33 | 8 | 12 | 78 | D | 133 | 50 | 27 | 7 | -1 | 2 | 0 | -2 | 1 | 0 | -3 | -3 | 5 | -11 |
2/13/15 17:07 | 2/11/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 1,047 | 37.52 | 33 | 28 | 61 | 74 | D | 134 | 44 | 31 | 7 | 3 | -7 | -2 | -2 | 0 | 7 | 4 | -1 | 12 | -12 |
2/13/15 17:07 | 2/11/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -3,351 | 120.12 | 33 | -28 | -27 | 74 | D | 134 | 44 | 31 | 7 | 3 | -7 | -2 | -2 | 0 | 7 | 4 | -1 | 12 | -12 |
1/2/15 16:01 | 12/30/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 694 | 29.75 | 33 | 23 | 66 | 59 | D | 185 | 32 | 24 | 20 | 5 | -3 | -5 | -1 | -1 | 1 | 5 | 1 | 5 | 6 |
1/2/15 16:01 | 12/30/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -2,185 | 113.37 | 33 | -19 | -25 | 59 | D | 185 | 32 | 24 | 20 | 5 | -3 | -5 | -1 | -1 | 1 | 5 | 1 | 5 | 6 |
11/14/14 16:13 | 11/12/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 1,055 | 32.90 | 33 | 32 | 141 | 55 | D | 189 | 44 | 46 | 20 | 13 | 4 | 2 | -1 | 0 | 3 | 7 | 11 | 11 | 3 |
11/14/14 16:13 | 11/12/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -4,227 | 107.23 | 33 | -39 | -42 | 55 | D | 189 | 44 | 46 | 20 | 13 | 4 | 2 | -1 | 0 | 3 | 7 | 11 | 11 | 3 |
8/5/14 16:14 | 8/4/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 1,308 | 28.16 | 33 | 46 | 295 | 62 | D | 156 | 19 | 18 | 18 | 2 | 1 | 1 | -1 | -1 | 0 | 10 | 23 | 35 | 51 |
8/5/14 16:14 | 8/4/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -3,423 | 87.55 | 33 | -39 | -39 | 62 | D | 156 | 19 | 18 | 18 | 2 | 1 | 1 | -1 | -1 | 0 | 10 | 23 | 35 | 51 |
5/5/14 18:16 | 5/1/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 694 | 59.50 | 33 | 12 | 74 | 27 | D | 102 | 24 | -3 | -3 | 2 | 8 | 2 | 0 | -1 | -1 | 5 | 17 | 44 | 48 |
5/5/14 18:16 | 5/1/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -1,750 | 146.78 | 33 | -12 | -30 | 27 | D | 102 | 24 | -3 | -3 | 2 | 8 | 2 | 0 | -1 | -1 | 5 | 17 | 44 | 48 |
3/5/14 16:20 | 3/3/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S | -383 | 159.05 | 33 | -2 | -8 | 28 | D | 121 | 53 | 16 | 0 | -4 | 1 | 1 | 0 | -4 | -3 | -10 | -5 | 17 | 47 |
12/31/13 16:26 | 12/27/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 0 | 0.00 | 33 | 8 | 52 | 23 | D | 148 | 117 | 42 | 10 | 12 | -1 | 4 | 1 | 2 | -3 | -9 | -13 | 5 | 34 |
11/5/13 16:02 | 11/1/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 0 | 0.00 | 33 | 10 | 112 | 19 | D | 137 | 106 | 24 | 6 | 3 | -3 | -5 | 0 | -4 | -2 | 6 | 0 | -4 | 40 |
8/2/13 17:46 | 8/2/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | M.d | 5,312 | 45.02 | 33 | 118 | | 14 | D | 151 | 114 | 50 | 25 | 31 | 11 | 10 | 4 | 0 | -4 | -5 | 3 | 3 | 17 |
8/2/13 17:46 | 8/2/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Karsen Perry A | NJ | O | see rema | S.d | -13,626 | 146.50 | 33 | -93 | -87 | 14 | D | 151 | 114 | 50 | 25 | 31 | 11 | 10 | 4 | 0 | -4 | -5 | 3 | 3 | 17 |